ALEMTUZUMAB (AL em TOOZ oo mab) is a monoclonal antibody. Campath is used to treat B cell chronic lymphocytic leukemia. Lemtrada is used to treat multiple sclerosis.
Alemtuzumab is a drug used in the treatment of chronic lymphocytic leukemia (
CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma under the trade ...
Learn about the prescription medication Campath (Alemtuzumab), drug uses,
dosage, side effects, drug interactions, warnings, reviews and patient labeling.
Nov 15, 2014 ... Alemtuzumab (Lemtrada) has received long-awaited FDA approval in relapsing
Los hombre y las mujeres deben usar métodos anticonceptivos efectivos durante el tratamiento y por lo menos 6 meses después de dejar de usar este medicamento. Call your doctor or health care professional if you are unable to keep an appointment.
Comuníquese con su méd... More »
Nov 14, 2014 ... UPDATED December 18, 2014. The U.S. Food and Drug Administration has
approved Lemtrada™ (alemtuzumab, Genzyme, a Sanofi ...
LEMTRADA®, because of its risks, is generally for relapsing MS patients who
have tried 2 or more MS medicines that didn't work well enough.
Jul 8, 2015 ... This is a summary of the most important information about Campath. For more
information, talk to your healthcare professional.
Dec 17, 2015 ... The biological therapy drug alemtuzumab is a treatment for chronic lymphocytic
leukaemia. The possible side effects inlcude an increased risk ...
Find patient medical information for alemtuzumab intravenous on WebMD
including its uses, side effects and safety, interactions, pictures, warnings and